IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. — Investor Relations & Filings
IMEIK Technology Development Co., Ltd. focuses on the research, development, and commercialization of biomedical materials, specifically targeting the aesthetic medicine sector. The company’s primary product line consists of injectable hyaluronic acid fillers and facial implants designed for soft tissue repair and augmentation. Utilizing proprietary cross-linking technologies, the firm produces high-purity formulations such as Hi-Tech and Hearty. Its portfolio also encompasses skin repair products and solutions for minimally invasive procedures. The organization prioritizes technological innovation and maintains a robust pipeline of Class III medical device registrations. By leveraging advanced biotechnology, the company provides clinical-grade materials to medical institutions and specialized clinics, emphasizing safety, efficacy, and biocompatibility in its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 爱美客2021年第三次临时股东大会决议公告 | 2021-08-05 | Chinese | |
| 2021年第三次临时股东大会的法律意见 | 2021-08-05 | Chinese | |
| 关于向香港联交所递交境外上市外资股（H股）上市申请并刊发申请资料的公告 | 2021-07-29 | Chinese | |
| 爱美客关于发行境外上市外资股（H股）申请材料获中国证监会受理的公告 | 2021-07-29 | Chinese | |
| 爱美客关于发行境外上市外资股（H股）申请材料获中国证监会受理的公告 | 2021-07-23 | Chinese | |
| 关于召开2021年第三次临时股东大会的通知 | 2021-07-20 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 38850686 | 爱美客2021年第三次临时股东大会决议公告 | 2021-08-05 | Chinese | ||
| 38850678 | 2021年第三次临时股东大会的法律意见 | 2021-08-05 | Chinese | ||
| 38850667 | 关于向香港联交所递交境外上市外资股（H股）上市申请并刊发申请资料的公告 | 2021-07-29 | Chinese | ||
| 38850660 | 爱美客关于发行境外上市外资股（H股）申请材料获中国证监会受理的公告 | 2021-07-29 | Chinese | ||
| 38850651 | 爱美客关于发行境外上市外资股（H股）申请材料获中国证监会受理的公告 | 2021-07-23 | Chinese | ||
| 38850643 | 关于召开2021年第三次临时股东大会的通知 | 2021-07-20 | Chinese | ||
| 38850634 | 第二届董事会第二十五次会议决议公告 | 2021-07-20 | Chinese | ||
| 38850623 | 海润天睿关于爱美客使用部分超募资金增资暨收购股权相关审议、审批程序之法律意见 | 2021-07-20 | Chinese | ||
| 38850611 | 关于使用部分超募资金增资暨收购韩国Huons BioPharma Co., Ltd.部分股权的补充公告 | 2021-07-20 | Chinese | ||
| 38850604 | 2021年第二次临时股东大会的法律意见 | 2021-07-12 | Chinese | ||
| 38850598 | 爱美客2021年第二次临时股东大会决议公告 | 2021-07-12 | Chinese | ||
| 38850589 | 2021年第二次临时股东大会会议资料（更新后） | 2021-07-08 | Chinese | ||
| 38850577 | 关于取消2021年第二次临时股东大会部分议案暨召开2021年第二次临时股东大会的补充通知 | 2021-07-08 | Chinese | ||
| 38850562 | 第二届董事会第二十四次会议决议公告 | 2021-07-08 | Chinese | ||
| 38850550 | 关于对深圳证券交易所关注函回复的公告 | 2021-07-02 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55863/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55863 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55863 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55863 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55863}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. (id: 55863)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.